Anti-apoptotic Serpins as Therapeutics in Cardiovascular Diseases

Author(s): Johan Kuiper, Paul H.A. Quax, Ilze Bot

Journal Name: Cardiovascular & Hematological Disorders-Drug Targets
Formerly Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 13 , Issue 2 , 2013

Become EABM
Become Reviewer
Call for Editor


Acute cardiovascular syndromes such as myocardial infarction and stroke are a major cause of death in the Western society and are generally caused by rupture of an atherosclerotic plaque. Treatment of atherosclerosis, the main underlying cause of acute cardiovascular syndromes, is still inadequate for most of the patients. Therefore, there is a need for new therapeutic strategies in addition to the existing lipid-lowering drugs such as statins. Lipid accumulation, inflammation and matrix degradation are generally considered key processes in the pathogenesis of atherosclerosis and that of plaque rupture. Furthermore, apoptosis or programmed cell death of plaque cells, depending on the disease stage, is thought to be of importance in the development and progression of atherosclerosis and the incidence of acute cardiovascular syndromes. Serine protease inhibitors or so-called serpins have been demonstrated to be involved in both the induction and inhibition of apoptosis and may thus be of interest as therapeutics in cardiovascular diseases such as atherosclerosis. In this review, we will discuss the current knowledge on the role of serpins in cardiovascular diseases with particular emphasis on apoptotic cell death and the potential therapeutic applications.

Keywords: Serpin, atherosclerosis, apoptosis, plaque stability, proteases.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 27 August, 2013
Page: [111 - 122]
Pages: 12
DOI: 10.2174/1871529X11313020004
Price: $65

Article Metrics

PDF: 37